Sensus Healthcare Announces Publication of Study Showing Use of Superficial Radiation Therapy Post-Keloidectomy Prevents Keloid Recurrence
October 22, 2020 08:00 ET
|
Sensus Healthcare, Inc.
Keloid recurrence rate of 10.4% at 12 months for patients treated with SRT following keloidectomy compares with more than 80% with surgical excision aloneRetrospective study published in Journal of...
Sensus Healthcare Reports Second Quarter 2020 Financial Results
August 06, 2020 16:02 ET
|
Sensus Healthcare, Inc.
BOCA RATON, Fla., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and...
American Society of Radiologic Technologists Approves Sensus Healthcare’s SRT Systems for Continuing Education Units
August 05, 2020 08:30 ET
|
Sensus Healthcare, Inc.
Beginning September 1, Category A credits will be available for in-person trainings on the SRT-100™, SRT-100+™ and SRT-100 Vision™ systems BOCA RATON, Fla, Aug. 05, 2020 (GLOBE NEWSWIRE) -- ...
Sensus Healthcare Acquires Two Mobile Aesthetic Laser Companies in Florida
August 04, 2020 08:30 ET
|
Sensus Healthcare, Inc.
Establishes new line of business, adds recurring revenue stream while more than doubling dermatology customer base across the stateExpected to add $1.0 million in revenues over the next 12...
Sensus Healthcare to Host Second Quarter 2020 Financial Results and Business Update Conference Call on August 6, 2020
July 30, 2020 08:30 ET
|
Sensus Healthcare, Inc.
BOCA RATON, Fla. , July 30, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological...
Sensus Healthcare Names Hoi-Bun “Benson” Suen Vice President of International Sales, Ships SRT-100™ to China
July 28, 2020 08:30 ET
|
Sensus Healthcare, Inc.
BOCA RATON, Fla. , July 28, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and...
Evidence-Based Guidelines Issued by ASTRO Support Sensus Healthcare’s SRT Technology as the First-Line Alternative to Surgery for Treating Non-Melanoma Skin Cancer
July 14, 2020 08:00 ET
|
Sensus Healthcare, Inc.
Influential professional organization recommends radiotherapy as the primary non-surgical alternative for patients with basal cell or cutaneous squamous cell carcinomas BOCA RATON, Fla, July 14,...
Sensus Healthcare to Present at COVID-19 Webinar Hosted by Maxim Group on July 16th
July 13, 2020 16:02 ET
|
Sensus Healthcare, Inc.
BOCA RATON, Fla., July 13, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological...
Sensus Healthcare’s CEO to Participate in Dermatology Practice Panel Discussion as Part of the Fall Clinical Virtual Grand Rounds Weekly Series
June 30, 2020 08:30 ET
|
Sensus Healthcare, Inc.
BOCA RATON, Fla. , June 30, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological...
Sensus Healthcare Announces CME Presentation by Dr. Jeffrey S. Fromowitz Today at the Fall Clinical Virtual Grand Rounds Series
June 24, 2020 08:30 ET
|
Sensus Healthcare, Inc.
BOCA RATON, Fla, June 24, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both...